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Abstract: 
Currently in clinical trials, microbicides have historically been promoted as a woman-controlled 
(although more recently woman initiated) method of sexually transmitted infection (STI) 
prevention. The contradicition that exists in this rationale is that women's bodies, specifically the 
genitals, have been constructed as a negotiated space within sexual interactions. This study 
qualitatively explored the factors influencing 40 young women's use of a vaginal moisturizer 
(VM), utilized as a microbicide surrogate. The results indicated that use of the VM was 
dependent upon product characteristics (i.e., the lubricating qualities affect on sexual pleasure, 
timing of insertion), individual factors (i.e., reproductive health goals, experiences with side 
effects of existing contraceptive methods), and contextual factors (i.e., social norms). An 
understanding of these bodily and social issues may be beneficial in designing targeted 
educational campaigns and effective instructional materials as well as in facilitating positive 
dialogue around women's bodies and their sexuality. 
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Article: 
The desire for a woman-initiated disease prevention method has increased the attention on 
vaginal microbicides as a method for the prevention of sexually transmitted infections (STIs), 
including human immunodeficiency virus (HIV). Microbicides are substances that may reduce 
transmission of STIs (Wulf, Frost, & Darroch, 1999) and may also prevent pregnancy, although 
not all microbicides will be contraceptive (Harrison, Rosenberg, & Bowcut, 2003). Currently 
there are more than 30 microbicide formulas in differing phases of clinical trials, including two 
products in the final phase of clinical trials (Alliance for Microbicide Development, 2007). 
Development delays have primarily been attributed to the complex physiology of the vaginal 
environment and research funding mechanisms (Global Campaign for Microbicides, 2007). 
Similar to spermicides, which have shown a range of acceptability (Elias & Coggins, 2001), 
including women's discontent with timing of insertion (Raymonda et al., 2005), microbicides 
would be inserted into the vagina at each coital event. In addition to prevention properties, 
microbicides may impact sexual comfort and pleasure, as most formulas will have lubricating 
qualities (Braunstein & Van de Wijgert, 2005; Philpott, Knerr, & Maher, 2006; Zubowicz et al., 
2006). Therefore, microbicides offer a unique compromise between the reduction of infection 
risk and potential influence on sexual performance and pleasure. 
Historically, microbicide development has been situated in the need for a woman-controlled 
method of protection against STIs, as it is suggested that underlying gender inequalities limit 
women's abilities to protect themselves and ensure condom use (Elias & Heise, 1994; Potts, 
1994; Stein, 1990). Thus, the anticipated arrival of microbicides, a woman-controlled method, is 
considered by many to be a significant advancement in public health's efforts to control STI and 
HIV incidence. An inherent contradiction exists, however, in the promotion of a “woman-
controlled” method to be used by a woman for the protection of her own body. The rationale for 
microbicide development has been based on the assumption that women have less control than 
men in sexual decision making (Pulerwitz, Amaro, De Jong, Gortmaker, & Rudd, 2002). In 
suggesting that women actually do not have control of their bodies or their sexual behaviors, this 
argument implies that women may not, in fact, be able to effectively adopt a woman-initiated 
method. Much research has documented a gendered power imbalance in heterosexual 
relationships, for example, in terms of sexual and contraceptive negotiation and violence (Blanc, 
2001), which will be problematic for women as they negotiate and use microbicides within this 
relational context. Recent work in the United States has indicated, however, that some women 
describe more equal relational power dynamics and feel in control of their sexual bodies 
(Carpenter, 2002; Harvey, Bird, Galavotti, Duncan, & Greenberg, 2002). Thus, microbicides—if 
they become available—may be helpful in facilitating dialogue around these gender power 
issues, at least in the United States. 
To more fully understand how microbicides may (or may not) be used, it is essential to 
understand how people, more specifically women, negotiate heterosexual norms. The social rules 
governing relationships often transform women's bodies into a shared space. The physical 
requirements of heterosexual intercourse (vagina accepting the penis) suggest that a woman's 
body, specifically her genitals, becomes a cooperative space where others, primarily male 
partners, have significant influence on how the space is defined. This is particularly relevant in 
the context of previous research suggesting women's sexual motivation is often based on a desire 
to please their male partners (Nicolson & Burr, 2003). The construction of women's bodies as a 
shared space suggests that women's preferences for microbicides need to be situated within the 
social context in which they will be used. 
Research on young women's sexuality has generally adopted a deficit approach. It has 
problematized their (hetero)sexual behavior and reduced their sexuality to the potentially 
negative outcomes, such as unintended pregnancy and STI (for a critique see Fortenberry, 2003). 
Additionally, existing research has largely focused on the individual woman and ignored the 
broader cultural context in which her sexual behaviors occur. The intersection of multiple 
identities for young women—gender, ethnicity, age, and socioeconomic status—all play a role in 
how young women negotiate their sexuality, sexual behaviors, and contraceptive use (Dworkin, 
2005; Orbuch & Fine, 2003; O'Sullivan & Meyer-Bahlburg, 2003). A consequence of the 
problem-based approach to research on young women's sexual behavior is that little work has 
been conducted on their sexual pleasure (Welsh, Rostosky, & Kawaguchi, 2000) or sexual 
desire, suggesting a “missing discourse of desire” for young women (Fine, 1988; Fine & 
McClelland, 2006). 
Microbicides will be unique in having disease prevention properties and characteristics that may 
positively impact sexual performance, pleasure, and comfort. These qualities offer a catalyst to 
shift research on young women's sexuality from a problem-based to a broader gender and 
sexuality perspective. This broader approach is needed in microbicide research to provide a 
positive construction of young women's sexuality while at the same time examining the benefits 
of protection. Several researchers have suggested that it is time to address the overall healthy 
sexual development of young people (Tolman, 2006; Welsh et al., 2000). Welsh and colleagues 
(2000) proposed a framework including personal characteristics and ecological variables (i.e., 
culture, family and peer environments) as factors influencing young women's sexual behavior. 
The consideration of these factors is essential, especially for future microbicide use and 
acceptability, as social and cultural norms have considerable effects on sexual behaviors. 
In order to address the complex integration of a microbicide into the sexual repertoire of young 
women, it is important to understand the meanings associated with their bodies, sexual 
behaviors, sexual partners, and the product. Symbolic interactionism and sexual scripting theory 
are useful in framing how women associate meanings across a variety of contexts (Gagnon, 
1990; Gagnon & Simon, 1973; Longmore, 1998; Plummer, 2003). Symbolic interactionism 
focuses on shared understanding and is useful in considering the value that young women may 
place on microbicides (Longmore, 1998; Plummer, 2003). Sexual scripts exist at three different 
levels: intrapsychic, interpersonal, and cultural scenarios and allow individuals to determine the 
appropriate sequence of sexual interactions (Gagnon, 1990; Gagnon & Simon, 1973). These 
frameworks allow women to construct the role that sex plays in their lives and how these 
constructions are fluid depending on the physical and social environments. An understanding of 
how the sociocultural contexts influence sexual behavior scripts is useful in considering how 
microbicides may (or may not) be utilized in sexual interactions. 
The purpose of this study was to examine qualitatively the influence of specific factors on young 
women's use of a microbicide surrogate, a vaginal moisturizer (VM). As microbicides are not yet 
approved, some previous research has utilized VMs as surrogates for microbicides (i.e., 
Zubowicz et al., 2006) in order to assess the behavioral correlates of use above and beyond 
hypothetical product assessment. The specific aims of this study were to examine how factors 
related to individual and social characteristics as well as features of the product might affect use 
and sexual pleasure. A better understanding of the factors influencing use of a microbicide 
surrogate will be useful in the promotion of future microbicides. 
Method 
This study was part of an ongoing longitudinal study of young women's sexual health and 
behaviors with women recruited from urban community-based clinics in a large Midwestern city. 
The areas served by these clinics are characterized by high rates of STIs (Centers for Disease 
Control and Prevention [CDC], 2005) and early child-bearing (Ventura, Matthews, & Hamilton, 
2002) and low rates of HIV (Chicockin, 2008). All study protocols were approved by the 
university's Institutional Review Board. 
All women participating in the larger project, who were currently using the VM (N = 133), were 
invited to participate in this study component. Study recruitment continued until saturation was 
reached (Weiss, 1994), which resulted in a subsample of 40 young women over the age of 18. 
Written informed consent was obtained from each woman. Since microbicides are currently in 
clinical trials and therefore not yet commercially available, participants were asked to use a 
commercially available VM as a microbicide surrogate with each coital event for a 4-week 
period. The VM (Silken Secret by Astroglide®, BioFilm, Inc.©) was packaged in individual 5 
mL applicators. Although other available products may more closely resemble microbicide 
candidate properties, this product was used because its water-based property ensured safety when 
used with condoms. There are distinct similarities between the VM in terms of physical 
characteristics (i.e., smell, lubricating properties), with formulations of microbicides under 
development. Women were asked to use the entire individually packaged application of the VM 
with each coital event over the course of the study period. As we were interested in using the 
VM as a VM surrogate, the VM instructions were for vaginal intercourse; none of the 
participants asked questions regarding use with other activities (e.g., anal sex), but a few 
mentioned concerns with application before oral sex. Specific information was given about the 
VM, emphasizing that it did not have any disease prevention or contraceptive properties. 
As required by the larger study protocol, the young women were randomized into three different 
timing conditions for VM application to mimic possible microbicide specifications (1 hour 
precoitus, 5–10 minutes precoitus, or 5–10 minutes postcoitus). In addition, structured daily 
diaries were completed each day of the 4-week period, even if the VM was not used, to obtain 
information related to demographics, VM use patterns, participation in sexual activity, and 
partner-specific information (i.e., perceptions of partners' assessment of VM). Over the course of 
the larger study (approximately 36 months), all women will complete each 4-week timing 
condition twice. 
At the completion of a VM cycle, 45 individual interviews were conducted with 40 young 
women. Of these, 40 were conducted following the women's first or second VM cycle, and an 
additional five follow-up interviews were conducted 6 months later following the subsequent 
VM cycle to obtain a more even distribution across timing conditions. None of the women 
invited declined to participate, although an additional woman was recruited as one woman was 
unable to attend her interview. Participants did not receive compensation for the interview or for 
using the VM but received a $3 per day stipend for completing the structured diaries. 
Study Participants 
Participants were 40 young women between the ages of 18 and 23 years (M = 19.5 years, SD = 
1.4). Of these women, 85% (n = 34) were African American and 15% (n = 6) were Euro-
American. Most of the women were attending high school (17.5%, n = 7) or had 
graduated/obtained their GED (32.5%, n = 13). An additional 20% (n = 8) were pursuing higher 
education, and 17.5% (n = 7) had dropped out of high school. About half of the women (47.5%, 
n = 19) had one or more children at the time of the interview. 
The women were distributed across the different VM timing conditions. At the initial interview, 
17 (42.5%) women were in the 5–10-minute precoital condition, 14 (35%) were in the 5–10-
minute postcoital condition, and nine (22.5%) were in the 1-hour precoital condition. At follow-
up, three women (60%) were in the 1-hour precoital condition and one woman (20%) each were 
in the 5–10-minute pre- and postcoital conditions. Over half (55%, n = 22) had used the VM in 
multiple cycles over the course of the larger study. The majority (92.5%, n = 37) of the women 
had used the VM during the 4-week period prior to the initial interview, and all five had used it 
at the follow-up interview. Of the three women who had not used it during the month before the 
interview, two had used it in a previous cycle and only one had never used the VM. The women 
used the VM with 107 of the 164 (65.2%) reported coital events, with condom use reported for 
53 (32.3%, n = 53) of these events. 
Data Collection and Study Measures 
Demographic data were collected via the larger study protocol (see Fortenberry et al., 2005). The 
qualitative interviews were conducted by the first author (a 28-year-old Euro-American woman) 
with the 40 young women. In order to increase comfort in discussing sexuality-related topics and 
reduce the likelihood of socially desirable responding, all interviews were conducted at a 
confidential location of the women's choosing (i.e., her house, friend's house). All names have 
been changed to pseudonyms to protect the women's identities. Interviews lasted on average 
about 30 minutes (range 16–51 minutes). 
The interview guide was developed utilizing symbolic interactionist (Longmore, 1998) and 
sexual scripting theory (Gagnon & Simon, 1973) constructs. The authors, with feedback 
provided by seven of the research staff from the larger study, developed the interview guide, 
which was composed of open-ended questions designed to elicit information about young 
women's experiences with the VM. Interview guides were tested with an ethnically diverse group 
of four research assistants, including women the same age and race (African American and Euro-
American) as the study sample. Topics discussed during the interview included experience using 
the VM (e.g., What were your reasons for deciding not to use the VM?), assessment of the VM 
(e.g., Did the VM make sex feel different?), and contextual factors influencing use (e.g., What 
do/would your family think about you using the VM?). 
Data Management and Analysis 
To assess the demographic variables, descriptive statistics were conducted using SPSS 14.0 
(SPSS, 2006). The interviews were digitally recorded and transcribed verbatim. Management and 
analysis of the interview data were conducted with the assistance of Atlas ti 5.0 (Muhr, 2004). 
Content analysis identified themes related to VM use based on emergent themes (Weiss, 1994). 
In addition to the first author, two research assistants, both young Euro-American women the 
same age as the participants, participated in the data analysis component to increase reliability of 
the analysis. Independent codings were compared and indicated high consistency among raters, 
with any discrepancies resolved via discussion. After reviewing multiple potential quotes for 
relevance, clarity, context, and brevity, quotes are presented that best represented the emergent 
themes illustrating the commonalities and individual variation among the young women. 
Results 
Overall, there was substantial variability in young women's stated acceptability of the VM. Most 
women (n = 25, 62.5%) evaluated the VM as “okay” or neutral, seven (17.5%) assessed it very 
positively, five (12.5%) had negative evaluations, and three (7.5%) had not used the VM during 
the 4 weeks prior to the interview, with one woman never using it. Some women reported that 
they would be uninterested in using a microbicide because they did not like the concept, like 
Dorothy (18) who thought “it [VM] was weird.” In addition, one woman was adamant about not 
using the VM because “I don't like that kind of stuff. Putting stuff in me, it's nasty to me” 
(Nicole, 18). On the other hand, some women who were initially hesitant exclaimed, “Yes, I do 
like using it!” (Danielle, 18) and “I can't wait for it [microbicides] to come out!” (Crystal, 18). 
Three themes that reflected individual and contextual factors that were associated with VM use 
emerged from the data. The themes influencing young women's acceptability and use of 
microbicides were related to preferences regarding product characteristics as well as individual 
and contextual factors. 
Product Characteristics 
Young women's personal assessment of using the VM was influenced by specific product 
characteristics, including the lubricating qualities and the timing of use. 
Lubricating qualities 
Many young women conveyed their personal evaluation of the VM in terms of messiness. The 
messiness was positive for some women, “Yeah, it was cool, it was just messy” (Lisa, 23) and 
neutral for others, “Messy but wet, I guess, slippery” (Linda, 22). Several women felt that some 
of the messiness was due to the product volume, suggesting it was “a whole lot” (Dorothy, 18), 
which led to some decreasing the amount of VM inserted into the vagina. Some women did not 
like the “gooshiness” of the VM (Cynthia, 23), while others were accepting of a little bit of 
“messiness” as the “wetness” or lubricating quality of the VM increased their enjoyment of sex. 
Danielle (18) evaluated the VM and the intercourse that followed as “messy, very greasy, and 
better because more wetter from being so greasy.” Karen (21) said, “I thought it was pretty good. 
It stayed wet, it stayed creamy. I mean, yeah, it was good.” Brenda (21) reported neutrally that 
the VM “makes you feel like you have moisture in there.” Rose's (20) enjoyment of the 
lubricating qualities was tempered by the interruption: “I like it [VM] because I be real wet,…but 
I hate stopping to go put it in.” 
The lubricating quality was a highlight for the few women who experienced vaginal dryness 
during sex. Beverly (22) reported that the VM “makes it [sexual intercourse] easier and adds 
comfort,” and Gloria (18) appreciated the VM, especially with condoms, as sometimes “it takes a 
while for your juices to get going.” In addition, a few women mentioned that it helped if they 
were “not really in the mood for it [sexual intercourse]” (Cynthia, 23). The discussion of 
increased lubrication associated with VM use was generally a positive or neutral influence on 
young women's sexual experience. 
Timing of VM use 
The ease or difficulty associated with VM use was often dependent on the women's assigned 
timing condition (i.e., one hour precoital, 5–10 minute precoital, or 5–10 minutes postcoital). 
Over the course of all the interviews, most of the women (n = 26, 65%) had used the VM in 
multiple timing conditions and were able to compare experiences associated with timing of 
insertion. The ability for some of these young women to plan for sex or know when it may occur 
was limited. Therefore, for many women it seemed an unrealistic requirement to use a 
microbicide an hour before sex. Evelyn (21), like other women, suggested that use would be best 
“maybe 10 minutes before or something like that, but no more than a half an hour before.” Some 
women felt that even this timing window would be unacceptable because “nobody knows 5–10 
minutes before they are going to have sex, I don't think sex is planned” (Deborah, 20). In 
addition, Melissa (18), who used the VM for the second time in the 1-hour precoital condition, 
reported, “I didn't like it [this time] at all, it was like it had too much that had to be planned in 
order to do it right.” 
Women were concerned not only about planning for sex but also about the disturbance to the 
sexual interaction: “It interrupts everything!” (Melissa, 18). This was especially an issue with 
application that required waiting a certain amount of time before having sex as it interrupted the 
flow of the sexual event, “because you don't know when you're going to be doing it; sometimes it 
just happens. I mean, I'll be in the mood and then be like, ‘hold on, give me 2 minutes’” (Mary, 
18). 
Several women discussed the coitus-dependent nature of VM, with a few appreciating the event-
specific use of a microbicide compared with other methods that “you got to take everyday” 
(Gloria, 18). Other women wanted to separate use from the event altogether: “It's easier [than 
condoms], as you could do it an hour before sex and wouldn't have to worry about it” (Elizabeth, 
19). Another woman, however, suggested waiting would be challenging: “An hour later you 
would be like, ‘Forget it. I don't even want to anymore,’” (Deborah, 20). This separation was 
more appealing to women who struggled with communicating about use, like Denise (19) who 
would prefer postcoital application because it is “hard to talk presex and easy to use after 
because women wouldn't have to talk.” Concerns existed, however, with postcoital application, 
including not wanting to get up afterward to use it (e.g., “Some people aren't going to remember, 
‘Oh, I've got to get up and put it in,’” Deborah, 20) and not having the lubricating and prevention 
benefits of the product (e.g., “Afterwards would be kind of weird, because that would, that would 
defeat the purpose.” Patricia, 20). 
The perceptions of effectiveness of potential microbicides were also affected by the timing of 
application. Many women indicated that a microbicide used before sex would be the only way it 
could be effective, “if it's meant to use against STDs, don't you think [before], yeah” (Sandra, 
20). Lisa (23) felt that “Five to 10 minutes afterwards, that would be too much time for 
something to start manifesting to start to protect yourself.” Others, however, thought that a 
postcoital application would be a better option as it would “catch whatever is in there” (Patricia, 
20). The fact that the women were using a product that did not actually have prevention 
characteristics influenced use with some women not using it much during the study but reporting 
that if it had prevention properties they would “definitely use it” (Virginia, 19) and “use it a lot” 
(Patricia, 20). Another woman added, “I think it would be cool to use if it were like a real 
contraceptive, ‘cause it was easy. You just twist it [put it into the vagina with the applicator]” 
(Melissa, 18). 
Individual Factors 
Young women's use of the VM was frequently dependent upon individual factors, including their 
reproductive health goals and their sexual contraceptive experiences. 
Reproductive health goals 
Pregnancy was a salient issue to all of the women, regardless of whether they were trying to 
conceive or to prevent pregnancy. Thus, interest in specific microbicide formulas was clearly 
influenced by their reproductive health goals. The presence of children had a strong impact on 
attitudes toward potential microbicide use. About half of the women interviewed had children at 
the time of the interview. For these women, the opportunity to engage in sex and use the VM was 
limited, “That's what it is, because I don't exactly know when because kids.…It makes it harder 
to actually plan it [sexual intercourse]” (Patricia, 20). In addition to the impact of the presence of 
children on the ability to use the VM, current reproductive health goals of the young women 
influenced their interest and motivation to use a microbicide. Motivation and adherence to 
current contraceptive methods was heightened for women who already had children and did not 
want any more: “I gotta baby already, I don't need to be trying to have another one” (Deborah, 
20). Women were willing to go to extreme lengths for pregnancy protection; for example, Lisa 
(23), a mother of two, would opt for triple protection, using the microbicide, condoms, and 
Depo-Provera®. Conversely, other women would prefer to use their current method of 
contraception, like Helen (19), a mother of one, who was uninterested in using a microbicide as 
she was satisfied with her use of the patch. 
For women who did not currently have children, pregnancy prevention remained a salient issue. 
For instance, Regina (19) indicated an interest in microbicides with contraceptive properties, 
“Because I wouldn't wanna get pregnant and I wouldn't wanna use my condoms.” Several 
women had very personal experiences that increased their attention to pregnancy prevention, 
including one woman who had lost a 4-week-old son when she was 18 and another woman who 
recently experienced a miscarriage. These women were particularly interested in microbicides 
with pregnancy prevention properties. 
For women who reported, “We're actually trying to get pregnant” (Gloria, 18), there was a low 
level of interest in microbicides with contraceptive properties. Sexually transmitted infection 
(STI) prevention, however, remained important for these women. Barbara (19) was interested in 
a specific microbicide formula: “Not with the pregnancy for me, but the STDs, yes,” as she was 
actively trying to get pregnant. Beverly (22) was also still interested in the disease prevention 
properties of a microbicide even though she was married and had undergone tubal ligation after 
the birth of her fourth child. 
Side effects of available methods 
The majority of women discussed issues related to side effects of existing contraceptive and 
disease prevention methods. The negative experiences associated with use of existing, 
particularly hormonal, methods increased perceived attractiveness of a microbicide for some 
women in comparison to existing methods. Many women, even those with a neutral or negative 
assessment of the VM, thought that a microbicide would be easier because “It's like a one-step 
process instead of remembering to count the days and stay on track with the birth control and 
always using a condom” (Linda, 22). Cynthia (23) summarized some of the women's opinions 
about future microbicide use: “Yes, I believe every female would probably be interested in that 
as long as it had no side effects to it.” 
Side effects were discussed in terms of the depot medroxy-progesterone acetate (Depo-
Provera®) injection and spermicides: “Well, I took the shot one time and I gained 30 pounds, 
and then I can't use spermicide because it irritates you” (Evelyn, 21); oral contraceptives and the 
patch: “The pill, I got pregnant on the pill. The patch I don't like. It irritates my skin; it makes my 
stomach hurt” (Jessica, 19); and condoms: “Condoms sometimes they break, anything can 
happen” (Linda, 22). Some women reported being dependent upon condoms for pregnancy and 
disease prevention, while other women felt that condoms decreased sensation, stating they “take 
out the feeling; it doesn't feel the same” (Sherry, 20). There was a preference among some 
women for a microbicide over condoms to enhance the physical sensation. This was true even for 
women like Jessica (19), who did not really like the VM but indicated interest in use to increase 
sexual sensation that was reduced for her (and her partner) by condom use. 
Sexual experiences 
Sexual experiences contributed to young women's motivation to use the VM. There was marked 
variability in how women discussed their sexual decisions and experiences. A few women 
described their experiences as very positive, emphasizing pleasure and reciprocity, while others' 
experiences clearly fell into traditional discourses about young women's sexuality. Many women 
reported that they enjoyed sex immensely; however, they also often indicated that they engaged 
in sex even when they were not in the mood. This was highlighted by a woman who recently had 
a miscarriage, but continued to feel the need to participate in sexual activity. She reported, 
“Sometimes I'm not really feeling it. We try to work it out with me giving him oral sex.…I 
understand that he wants to do what he wants to do, but I also have my own feminine problems” 
(Melissa, 18). This negotiation process suggests that in a heterosexual context some women may 
not always feel that they have the ability to say no (or yes) to sex. 
The necessity for women to engage in sex and the social construction of marriage as the 
appropriate context for sex in order to protect themselves was illustrated by Angela (19): 
And I tell them [my cousins], sex can wait, it's not that important. What if they end up, wound up 
pregnant or with a disease that they can't get rid of and then what? People should wait to have 
sex until they're older or until they're married. I wish I was still a virgin. I wish I would've waited 
until I was married to even think about having sex. 
A woman's control of her body was crucial and as such decisions were carefully made to protect 
reputations: “I didn't make myself as a whore. I didn't make myself letting everybody know I was 
doing it, none of that, so that was the main thing” (Cynthia, 23). The protection of their 
reputation, and to a lesser extent their body, was viewed as more important for some women than 
their ability to find pleasure in the interaction. 
With young women's desire to protect their reputations and themselves, many were adamant 
about wanting to use a microbicide when they become available, even if they had a neutral or 
negative assessment of the VM. This underscored the importance that they placed on self-
protection: “So, truthfully, I could care less whether he wanna try it or not. I'm trying to protect 
myself” (Cynthia, 23). Microbicides were viewed as a way to have control over the prevention 
method that would allow them to be less dependent on men. Margaret (19) illustrated this idea: 
“Yes, because you are doing it yourself. Like you could tell someone to put on a condom, but 
they won't. But you could tell yourself, ‘Okay, I'm gonna use this so I'm gonna use it.’” This 
control allowed for a higher level of excitement for a future microbicide: “Oh yes, I'm using it! 
I'm there. I'm squeezing it every time. I don't care what the man's got to say about it” (Crystal, 
18). 
Contextual Factors 
Social norms and networks were also an influence on VM use, as women's peers strongly 
influenced their sexual behaviors. The majority of the women engaged in intercourse at the same 
age as their friends. Danielle (18), for example, “lost her virginity” when she was 15 years old, 
the day after her best friend. Peer influence was also illustrated by women's indication that their 
friends would use microbicides if they told them to; for instance, Crystal (18), who really 
enjoyed using the VM, stated, “And I will let my friends know that it is coming out, ya'll better 
use it because it's good.” Social support for prevention methods was seen in the dispersion of 
microbicide knowledge as well as in sharing sexual and contraceptive experiences. 
Differences in attitudes toward pregnancy prevention were apparent between women who 
perceived social support for their pregnancy or not. Several women indicated a pregnancy would 
be acceptable to themselves, their family, and their partners. Crystal (18) illustrated her family's 
response to a potential pregnancy: 
There's nothing that they can say, because I'm grown. But all of them want me to have a baby. 
As soon as I turned 18, they were like, “So when are you having a baby?” Because my brother's 
baby, he just had a baby, and now they're like, “So when are you having a baby?” And I was 
like, “no time soon.” 
The cultural norms surrounding pregnancy created an environment in which motherhood was not 
only accepted but not having children was highly visible. For instance, Beverly (22) described 
her friend as “the only 22 year old that I know who doesn't have kids.” Social and cultural 
norms, in addition to sexual experiences, will likely play an important role in initiation and 
continued use of microbicides. 
Discussion 
The purpose of this study was to examine the individual and contextual factors influencing 
young women's use of a VM, used as a microbicide surrogate, given that these factors may offer 
insights into future microbicide acceptability and use. Overall, the results suggested that young 
women had varying levels of interest in VM use and in potential microbicides. Consistent with 
symbolic interactionism and sexual scripting theory (Gagnon, 1990; Gagnon & Simon, 1973; 
Longmore, 1998; Plummer, 2003), young women's use of the VM was impacted by their 
personal understanding and assessment of the VM and was influenced by factors at the 
individual and social levels. Although issues such as mode and timing of delivery remained 
salient to the young women's experience with VM use, factors influencing use were not limited 
to personal preferences for product characteristics. Also included in the decision-making process 
were young women's life experiences and situations as well as their sociocultural context. 
This research confirms and expands on previous microbicide acceptability research, which 
focused on the acceptability of specific product characteristics (Coggins et al., 2000; Short, 
Mills, Majkowski, Stanberry, & Rosenthal, 2003, 2004). While preferences for specific 
hypothetical product characteristics have been examined, this study allowed for the examination 
of young women's preferences and negotiation with use of a VM. Additionally, the results 
illustrated a range in women's willingness and desire to use microbicides, which will be 
important considerations in microbicide promotion and education once they become available. 
Similar to a prior study, several women who reported that the VM was “messy” dealt with this 
by using less of the product than recommended (Coggins et al., 1998). The VM volume was 
similar to the microbicides now in clinical trials, chosen for an appropriate concentration of 
active ingredients and adequate coverage of the vaginal surface. Therefore, while this adjustment 
allowed women to continue using the VM, it may have implications regarding the ultimate 
effectiveness of microbicides. In this context, the promotion of microbicide use in conjunction 
with other methods may help increase overall effectiveness. In general, a wide range of 
individual variation existed in terms of young women's evaluation of specific product 
characteristics, highlighting the complicated nature of microbicide acceptability. 
Consistent with previous work, several of the young women's evaluations of the VM focused on 
enhanced sexual pleasure because of increased “wetness” or lubrication (Philpott et al., 2006; 
Zubowicz et al., 2006). The lubricating quality may keep women (and their partners) motivated 
to use the product and should be emphasized in microbicide promotion. Given that many women 
expressed antipathy toward using condoms as they reported a decrease in sexual sensation, 
microbicides could provide a unique intersection of increasing protection and pleasure allowing 
women to acknowledge their own sexuality. Microbicides, therefore, have the potential to create 
an environment ripe for promoting positive, healthy sexual development for young women. 
Several of the women mentioned that a lubricating microbicide would be helpful if they were 
“not in the mood.” Locating a singular physical sign, namely, vaginal lubrication, for sexual 
arousal does not allow women to fully explore their body's sexual sensations or appreciate their 
own bodies and sexuality. Existing research has demonstrated that lubrication is only one of the 
physical changes that women experience when sexually aroused and not necessarily the most 
important (e.g., women may report sexual arousal when they are not lubricated or lubrication 
may occur when women are not aroused; Graham, Sanders, Milhausen, & McBride, 2004). 
Women may have been more tolerant of the increased lubrication with the VM because they 
perceived that this would increase their partner's pleasure, similar to women's desire for orgasm 
not for themselves but to please their male partners (Nicolson & Burr, 2003). It could also be 
suggestive of the discordance of gendered sexual discourses and power imbalances that exist in 
sexual relationships where women are not always enjoying sexual intercourse but are still 
expected to have it (e.g., Nicolson & Burr, 2003; Phillips, 2000). 
The majority of young women had a desire for microbicides having both disease and pregnancy 
prevention. The saliency of pregnancy (desired and unintended) as well as STI risk for these 
young women suggest that microbicides may be a suitable alternative for protection. 
Reproductive health goals have been shown to be a strong contributor to the likelihood of 
contraceptive use (Stone & Ingham, 2002). Thus, a nonbarrier disease prevention method may be 
an attractive alternative. Microbicide promotion will require health care providers to attend to 
young women's specific context, for example, suggesting appropriate formulations to increase 
the likelihood of use for STI protection while respectfully acknowledging their reproductive 
choices. 
Due to negative experiences with other, mainly hormonal, methods, many women thought a 
microbicide with contraceptive properties would be a good alternative. Young women's 
discussions of the difficulties associated with use of existing methods often included an implicit 
message that using a microbicide would be easier. The mainly unquestioned belief that 
microbicides will not have any of the negative side effects associated with hormonal 
contraception also increased their attractiveness as an alternative method. At the same time, 
many women worried that the coitus-dependent nature of microbicide use could present 
difficulties. Specifically, they felt microbicides, like condoms, may disrupt the flow of sexual 
interactions. 
The generally positive assessment of the VM in relation to experiences with hormonal 
contraceptive use illustrates one of the disadvantages with the evaluation of surrogate or 
hypothetical products (Elias & Coggins, 2001). That is, it is easy to emphasize the benefits of the 
product while not experiencing the potential side effects associated with actual use of a 
microbicide, for example, vaginal itching or burning. Conversely, because the VM had no 
antimicrobial properties, it is possible that some young women would be willing to tolerate some 
degree of discomfort and side effects to achieve the goal of disease prevention that will be 
provided by actual microbicides, especially if the formula also met their reproductive goals. 
The use of the microbicide surrogate was accompanied by a noticeable lack of discussion about 
the genitals. This may be reflective of the general abstraction of sexual behaviors from the body 
where it is possible to discuss heterosexual intercourse and use of a vaginal moisturizer without 
directly discussing the vagina. The heterosexual act of intercourse, with the vagina accepting the 
penis, requires a level of compromise and cooperation. The use of a microbicide within the 
vagina illustrates how much of that negotiation is defined by the woman's body and highlights 
the complex contradictions of a “woman-controlled” method. The incorporation of a positive 
dialogue around women's bodies, in addition to gendered power structures, is essential; it is 
impossible to separate a woman's experience using a microbicide from her body, as they are 
intimately intertwined. 
The population of women involved in the study may be unique in their willingness to use a VM 
and respond to questions about their sexual lives, and as such their experiences may not be 
representative of experiences other women may report. An important strength of the study was 
the fact that because of the protocol of the larger project, requiring weekly home visits, 
relationships developed between the first author and the young women interviewed. These 
relationships did not seem to be affected by the racial differences between the author and some 
of the participants. The development of a relationship between researchers and participants is 
noted as a helpful component of qualitative research (Huygens, Kajura, Seely, & Barton, 1996) 
and likely allowed for a higher level of disclosure about sexuality-related issues, even for more 
reserved women. In addition, the ways in which young women conceptualized the meaning of 
the product (i.e., as a lubricant, as a potential prevention method) was and will continue to be a 
factor in the use of a surrogate microbicide product and a microbicide when it becomes available. 
The conceptual framework (symbolic interactionism and sexual scripting theory) structuring the 
interview guide strengthened the study by allowing these issues to be explored with the young 
women. 
The contexts in which these young women negotiated VM use and their sexuality fit into a 
normative perspective of young people's sexual development (Welsh et al., 2000), which 
emphasizes the saliency of personal and ecological variables. Addressing the sociocultural 
contexts and social networks in which sexual behaviors and decisions occur is essential not only 
in microbicide promotion but also in the promotion of positive sexual development for young 
women. Therefore, the consideration of these factors allows for a better understanding of young 
women's sexuality and sexual health. The multiple factors discussed in this study, including the 
individual, family, and peers, all contributed to young womens decisions about (quite literally) 
what to put into their vaginas and illustrate the complexity of women's relationships with their 
bodies. 
Despite the limitations of the current study, the findings contribute to our understanding of the 
individual and contextual factors that may influence acceptability and use of microbicides, 
including a discussion of sexual pleasure. Further research to elucidate these factors would be 
beneficial in designing appropriate microbicide formulations as well as targeted educational 
campaigns and effective instructional materials. 
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